BioLargo Strengthens Intellectual Property Portfolio With Two New U.S. Patents

SANTA ANA, CA–(Marketwired – Jul 1, 2014) –BioLargo, Inc. (OTCQB: BLGO) announced it was issued two new patents by the United States Patent and Trademark Office (“USPTO”) further strengthening its growing patent portfolio and demonstrating multiple technical fields for application of the company’s advanced iodine platform technology.

U.S. Patent number 8,757,253 was issued on June 24, 2014 for the moderation of oil extraction waste environments, and U.S. Patent number 8,734,559 was issued on May 27, 2014 for the moderation of animal waste environments. Both patents validate and further protect BioLargo’s advanced iodine technology, which utilizes iodine chemistry and polymer science for providing increased performance and functionality of flocculants to bind and extract contaminants and to enhance odor and microbial control. The patents focus on the company’s technology applications within oil and gas waste streams and agriculture waste streams.

Dennis Calvert, President of BioLargo, stated: “These new patents further validate the usefulness of our advanced iodine technology in multiple areas of interest. Through our commercial scale pilot work with the University of Alberta, we have demonstrated the significant role our Advanced Oxidation System (AOS) Filter technology can have on oil and gas wastewater treatment, as well as in agriculture and food processing. These two new patents complement our AOS Filter by demonstrating the usefulness of our technology in providing simple and sustainable technical solutions to help industries create clean operating environments.”

Additional information about the patents granted to BioLargo, Inc. can be accessed on the USPTO website at www.uspto.gov.

About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) makes life better by delivering technology-based products that help solve some of the world’s most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at  www.BioLargo.com. The subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a “Top 50 Water Company for the 21st Century” award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature’s Best Solution® and Deodorall® brands. (www.OdorNoMore.com). The subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com), focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2014.

Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2013.